Free Trial

Q1 Earnings Estimate for Enhabit Issued By Leerink Partnrs

Enhabit logo with Medical background

Enhabit, Inc. (NYSE:EHAB - Free Report) - Equities researchers at Leerink Partnrs issued their Q1 2026 earnings estimates for shares of Enhabit in a report issued on Sunday, May 11th. Leerink Partnrs analyst W. Mayo anticipates that the company will post earnings of $0.12 per share for the quarter. The consensus estimate for Enhabit's current full-year earnings is $0.22 per share. Leerink Partnrs also issued estimates for Enhabit's Q2 2026 earnings at $0.13 EPS, Q3 2026 earnings at $0.12 EPS, FY2028 earnings at $0.22 EPS and FY2029 earnings at $0.32 EPS.

Enhabit (NYSE:EHAB - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The company reported $0.10 earnings per share for the quarter, beating analysts' consensus estimates of $0.07 by $0.03. Enhabit had a negative net margin of 11.24% and a positive return on equity of 1.67%. The firm had revenue of $259.90 million for the quarter, compared to analyst estimates of $266.11 million.

Separately, Jefferies Financial Group reissued a "buy" rating on shares of Enhabit in a research report on Thursday, March 6th.

Check Out Our Latest Stock Report on EHAB

Enhabit Trading Up 1.5%

Shares of Enhabit stock opened at $10.44 on Tuesday. The business has a fifty day simple moving average of $8.36 and a 200-day simple moving average of $8.11. Enhabit has a fifty-two week low of $6.85 and a fifty-two week high of $10.95. The firm has a market cap of $528.40 million, a price-to-earnings ratio of -4.50 and a beta of 1.61. The company has a quick ratio of 1.46, a current ratio of 1.46 and a debt-to-equity ratio of 0.85.

Institutional Investors Weigh In On Enhabit

Hedge funds have recently modified their holdings of the company. Deerfield Management Company L.P. Series C raised its position in shares of Enhabit by 0.3% during the 4th quarter. Deerfield Management Company L.P. Series C now owns 5,010,972 shares of the company's stock worth $39,136,000 after acquiring an additional 13,226 shares in the last quarter. 8 Knots Management LLC lifted its stake in shares of Enhabit by 16.4% in the fourth quarter. 8 Knots Management LLC now owns 4,430,898 shares of the company's stock worth $34,605,000 after acquiring an additional 623,602 shares in the last quarter. Vanguard Group Inc. raised its stake in Enhabit by 1.6% during the first quarter. Vanguard Group Inc. now owns 2,960,343 shares of the company's stock worth $26,021,000 after acquiring an additional 47,640 shares during the period. AREX Capital Management LP raised its position in shares of Enhabit by 2.0% during the 4th quarter. AREX Capital Management LP now owns 2,490,795 shares of the company's stock worth $19,453,000 after buying an additional 48,874 shares in the last quarter. Finally, Systematic Financial Management LP raised its position in Enhabit by 8.6% during the fourth quarter. Systematic Financial Management LP now owns 1,996,113 shares of the company's stock valued at $15,590,000 after buying an additional 157,914 shares during the period.

About Enhabit

(Get Free Report)

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.

Featured Stories

Earnings History and Estimates for Enhabit (NYSE:EHAB)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Enhabit Right Now?

Before you consider Enhabit, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enhabit wasn't on the list.

While Enhabit currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 AI ETFs for Steady Gains in 2025 (Without the Wild Volatility)
Goldman Sachs Warns of 20% Market Drop—Are They Right?
Top 3 Insider Stock Buys in April—Are They Still Good in May?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines